Skip to main content
Top
Published in: Inflammation 1/2024

23-09-2023 | Candida Albicans | RESEARCH

MDA5 Enhances Invasive Candida albicans Infection by Regulating Macrophage Apoptosis and Phagocytosis/Killing Functions

Authors: Yayun Chen, Qian Jiang, Furong Qing, Junxia Xue, Qiuxiang Xiao, Wenji He, Lina Sui, Zhiping Liu

Published in: Inflammation | Issue 1/2024

Login to get access

Abstract

Candida albicans is a common opportunistic pathogenic fungus. The innate immune system provides the first-line host defense against fungal infection. Innate immune receptors and downstream molecules have been shown to play various roles during fungal infection. The innate immune receptor MDA5, encoded by the gene Ifih1, enhances host resistance against viral and Aspergillus fumigatus infection by inducing the production of interferons (IFNs). However, the role of MDA5 in C. albicans infection is still unclear. Here, we found that the gene expression levels of IFIH1 were significantly increased in innate immune cells after C. albicans stimulation through human bioinformatics analysis or mouse experiments. Through in vivo study, MDA5 was shown to enhance host susceptibility to C. albicans infection independent of IFN production. Instead, MDA5 exerted its influence on macrophages and kidneys by modulating the expression of Noxa, Bcl2, and Bax, thereby promoting apoptosis. Additionally, MDA5 compromised killing capabilities of macrophage by inhibition iNOS expression. The introduction of the apoptosis inducer PAC1 further impaired macrophage functions, mimicking the enhancing effect of MDA5 on C. albicans infection. Furthermore, the administration of macrophage scavengers increased the susceptibility of Ifih1−/− mice to C. albicans. The founding suggests that MDA5 promote host susceptibility to invasive C. albicans by enhancing cell apoptosis and compromising macrophage functions, making MDA5 a target to treat candidiasis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brown, G.D., D.W. Denning, and S.M. Levitz. 2012. Tackling human fungal infections. Science 336 (6082): 647.PubMedCrossRef Brown, G.D., D.W. Denning, and S.M. Levitz. 2012. Tackling human fungal infections. Science 336 (6082): 647.PubMedCrossRef
4.
go back to reference Magill, S.S., et al. 2014. Multistate point-prevalence survey of health care-associated infections. New England Journal of Medicine 370 (13): 1198–1208.PubMedCrossRef Magill, S.S., et al. 2014. Multistate point-prevalence survey of health care-associated infections. New England Journal of Medicine 370 (13): 1198–1208.PubMedCrossRef
5.
go back to reference Fisher, M.C., et al. 2018. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science 360 (6390): 739–742.PubMedCrossRef Fisher, M.C., et al. 2018. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science 360 (6390): 739–742.PubMedCrossRef
6.
go back to reference Netea, M.G., et al. 2015. Immune defence against Candida fungal infections. Nature Reviews Immunology 15 (10): 630–642.PubMedCrossRef Netea, M.G., et al. 2015. Immune defence against Candida fungal infections. Nature Reviews Immunology 15 (10): 630–642.PubMedCrossRef
7.
go back to reference Luisa Gil, M., et al. 2016. Role of toll-like receptors in systemic Candida albicans infections. Frontiers in Bioscience 21 (2): 278–302.CrossRef Luisa Gil, M., et al. 2016. Role of toll-like receptors in systemic Candida albicans infections. Frontiers in Bioscience 21 (2): 278–302.CrossRef
9.
go back to reference Strasser, D., et al. 2012. Syk kinase-coupled C-type lectin receptors engage protein kinase C-delta to elicit Card9 adaptor-mediated innate immunity. Immunity 36 (1): 32–42.PubMedPubMedCentralCrossRef Strasser, D., et al. 2012. Syk kinase-coupled C-type lectin receptors engage protein kinase C-delta to elicit Card9 adaptor-mediated innate immunity. Immunity 36 (1): 32–42.PubMedPubMedCentralCrossRef
10.
go back to reference Gross, O., et al. 2009. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459 (7245): 433–436.PubMedCrossRef Gross, O., et al. 2009. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459 (7245): 433–436.PubMedCrossRef
11.
go back to reference Hise, A.G., et al. 2009. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host & Microbe 5 (5): 487–497.CrossRef Hise, A.G., et al. 2009. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host & Microbe 5 (5): 487–497.CrossRef
12.
go back to reference Tomalka, J., et al. 2011. A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathogens 7 (12): e1002379.PubMedPubMedCentralCrossRef Tomalka, J., et al. 2011. A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathogens 7 (12): e1002379.PubMedPubMedCentralCrossRef
13.
go back to reference Borghi, M., et al. 2015. Pathogenic NLRP3 inflammasome activity during Candida infection is negatively regulated by IL-22 via activation of NLRC4 and IL-1Ra. Cell Host & Microbe 18 (2): 198–209.CrossRef Borghi, M., et al. 2015. Pathogenic NLRP3 inflammasome activity during Candida infection is negatively regulated by IL-22 via activation of NLRC4 and IL-1Ra. Cell Host & Microbe 18 (2): 198–209.CrossRef
14.
go back to reference Ding, X., et al. 2021. Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophages. Nature Communications 12 (1): 6699.PubMedPubMedCentralCrossRef Ding, X., et al. 2021. Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophages. Nature Communications 12 (1): 6699.PubMedPubMedCentralCrossRef
15.
16.
go back to reference Dias Junior, A.G., N.G. Sampaio, and J. Rehwinkel. 2019. A balancing act: MDA5 in antiviral immunity and autoinflammation. Trends in Microbiology 27 (1): 75–85.PubMedCrossRef Dias Junior, A.G., N.G. Sampaio, and J. Rehwinkel. 2019. A balancing act: MDA5 in antiviral immunity and autoinflammation. Trends in Microbiology 27 (1): 75–85.PubMedCrossRef
18.
go back to reference Wu, Y., et al. 2017. The anticancer functions of RIG-I-like receptors, RIG-I and MDA5, and their applications in cancer therapy. Translational Research 190: 51–60.PubMedCrossRef Wu, Y., et al. 2017. The anticancer functions of RIG-I-like receptors, RIG-I and MDA5, and their applications in cancer therapy. Translational Research 190: 51–60.PubMedCrossRef
19.
go back to reference Santin, I., and D.L. Eizirik. 2013. Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and beta-cell apoptosis. Diabetes, Obesity & Metabolism 15 (Suppl 3): 71–81.CrossRef Santin, I., and D.L. Eizirik. 2013. Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and beta-cell apoptosis. Diabetes, Obesity & Metabolism 15 (Suppl 3): 71–81.CrossRef
20.
go back to reference Wang, X., et al. 2020. MDA5 is an essential sensor of a pathogen-associated molecular pattern associated with vitality that is necessary for host resistance against Aspergillus fumigatus. The Journal of Immunology 205 (11): 3058–3070.PubMedCrossRef Wang, X., et al. 2020. MDA5 is an essential sensor of a pathogen-associated molecular pattern associated with vitality that is necessary for host resistance against Aspergillus fumigatus. The Journal of Immunology 205 (11): 3058–3070.PubMedCrossRef
21.
go back to reference Jaeger, M., et al. 2015. The RIG-I-like helicase receptor MDA5 (IFIH1) is involved in the host defense against Candida infections. European Journal of Clinical Microbiology and Infectious Diseases 34 (5): 963–974.PubMedCrossRef Jaeger, M., et al. 2015. The RIG-I-like helicase receptor MDA5 (IFIH1) is involved in the host defense against Candida infections. European Journal of Clinical Microbiology and Infectious Diseases 34 (5): 963–974.PubMedCrossRef
23.
go back to reference Czakai, K., et al. 2016. Kruppel-like Factor 4 modulates interleukin-6 release in human dendritic cells after in vitro stimulation with Aspergillus fumigatus and Candida albicans. Science and Reports 6: 27990.CrossRef Czakai, K., et al. 2016. Kruppel-like Factor 4 modulates interleukin-6 release in human dendritic cells after in vitro stimulation with Aspergillus fumigatus and Candida albicans. Science and Reports 6: 27990.CrossRef
24.
go back to reference Smeekens, S.P., et al. 2013. Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nature Communications 4: 1342.PubMedCrossRef Smeekens, S.P., et al. 2013. Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nature Communications 4: 1342.PubMedCrossRef
25.
go back to reference Bruno, M., et al. 2021. Comparative host transcriptome in response to pathogenic fungi identifies common and species-specific transcriptional antifungal host response pathways. Computational and Structural Biotechnology Journal 19: 647–663.PubMedCrossRef Bruno, M., et al. 2021. Comparative host transcriptome in response to pathogenic fungi identifies common and species-specific transcriptional antifungal host response pathways. Computational and Structural Biotechnology Journal 19: 647–663.PubMedCrossRef
26.
go back to reference Delaloye, J., and T. Calandra. 2014. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 5 (1): 161–169.PubMedCrossRef Delaloye, J., and T. Calandra. 2014. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 5 (1): 161–169.PubMedCrossRef
28.
go back to reference Myskiw, C., et al. 2011. RNA species generated in vaccinia virus infected cells activate cell type-specific MDA5 or RIG-I dependent interferon gene transcription and PKR dependent apoptosis. Virology 413 (2): 183–193.PubMedCrossRef Myskiw, C., et al. 2011. RNA species generated in vaccinia virus infected cells activate cell type-specific MDA5 or RIG-I dependent interferon gene transcription and PKR dependent apoptosis. Virology 413 (2): 183–193.PubMedCrossRef
29.
go back to reference Yu, X., et al. 2016. Activation of the MDA-5-IPS-1 viral sensing pathway induces cancer cell death and type I IFN-dependent antitumor immunity. Cancer Research 76 (8): 2166–2176.PubMedPubMedCentralCrossRef Yu, X., et al. 2016. Activation of the MDA-5-IPS-1 viral sensing pathway induces cancer cell death and type I IFN-dependent antitumor immunity. Cancer Research 76 (8): 2166–2176.PubMedPubMedCentralCrossRef
31.
go back to reference Banoth, B., et al. 2020. ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis). Journal of Biological Chemistry 295 (52): 18276–18283.PubMedCrossRef Banoth, B., et al. 2020. ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis). Journal of Biological Chemistry 295 (52): 18276–18283.PubMedCrossRef
32.
34.
go back to reference Gil, M.L., and D. Gozalbo. 2009. Role of Toll-like receptors in systemic Candida albicans infections. Frontiers in Bioscience 14 (2): 570–582.CrossRef Gil, M.L., and D. Gozalbo. 2009. Role of Toll-like receptors in systemic Candida albicans infections. Frontiers in Bioscience 14 (2): 570–582.CrossRef
35.
go back to reference Majer, O., et al. 2012. Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections. PLoS Pathogens 8 (7): e1002811.PubMedPubMedCentralCrossRef Majer, O., et al. 2012. Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections. PLoS Pathogens 8 (7): e1002811.PubMedPubMedCentralCrossRef
37.
go back to reference del Fresno, C., et al. 2013. Interferon-beta production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity 38 (6): 1176–86.PubMedCrossRef del Fresno, C., et al. 2013. Interferon-beta production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity 38 (6): 1176–86.PubMedCrossRef
38.
go back to reference Biondo, C., et al. 2011. Recognition of yeast nucleic acids triggers a host-protective type I interferon response. European Journal of Immunology 41 (7): 1969–1979.PubMedCrossRef Biondo, C., et al. 2011. Recognition of yeast nucleic acids triggers a host-protective type I interferon response. European Journal of Immunology 41 (7): 1969–1979.PubMedCrossRef
40.
go back to reference Liu, L., et al. 2011. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. Journal of Experimental Medicine 208 (8): 1635–1648.PubMedPubMedCentralCrossRef Liu, L., et al. 2011. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. Journal of Experimental Medicine 208 (8): 1635–1648.PubMedPubMedCentralCrossRef
41.
go back to reference van de Veerdonk, F.L., et al. 2011. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. New England Journal of Medicine 365 (1): 54–61.PubMedCrossRef van de Veerdonk, F.L., et al. 2011. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. New England Journal of Medicine 365 (1): 54–61.PubMedCrossRef
43.
go back to reference Zhang, Z., et al. 2018. Hepatitis D virus replication is sensed by MDA5 and induces IFN-beta/lambda responses in hepatocytes. Journal of Hepatology 69 (1): 25–35.PubMedCrossRef Zhang, Z., et al. 2018. Hepatitis D virus replication is sensed by MDA5 and induces IFN-beta/lambda responses in hepatocytes. Journal of Hepatology 69 (1): 25–35.PubMedCrossRef
44.
go back to reference Huo, W., et al. 2020. Caspase-3 inhibitor inhibits enterovirus D68 production. Journal of Microbiology 58 (9): 812–820.PubMedCrossRef Huo, W., et al. 2020. Caspase-3 inhibitor inhibits enterovirus D68 production. Journal of Microbiology 58 (9): 812–820.PubMedCrossRef
Metadata
Title
MDA5 Enhances Invasive Candida albicans Infection by Regulating Macrophage Apoptosis and Phagocytosis/Killing Functions
Authors
Yayun Chen
Qian Jiang
Furong Qing
Junxia Xue
Qiuxiang Xiao
Wenji He
Lina Sui
Zhiping Liu
Publication date
23-09-2023
Publisher
Springer US
Published in
Inflammation / Issue 1/2024
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-023-01903-5

Other articles of this Issue 1/2024

Inflammation 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine